Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled study
在一项 2/3 期、观察者盲法、随机、对照研究中，评估了 SII-NVX-CoV2373（COVID-19 疫苗）在成人中的安全性和免疫原性。
期刊:Lancet Regional Health - Southeast Asia
影响因子:6.2
doi:10.1016/j.lansea.2022.100139
Kulkarni, Prasad S; Kadam, Abhijit; Godbole, Sheela; Bhatt, Varsha; Raut, Abhishek; Kohli, Sunil; Tripathi, Santanu; Kulkarni, Praveen; Ludam, Rakhi; Prabhu, Madhav; Bavdekar, Ashish; Gogtay, Nithya J; Meshram, Sushant; Kadhiravan, Tamilarasu; Kar, Sonali; Narayana, D H Ashwath; Samuel, Clarence; Kulkarni, Govind; Gaidhane, Abhay; Sathyapalan, Dipu; Raut, Sidram; Hadda, Vijay; Bhalla, Hira Lal; Bhamare, Chetanraj; Dharmadhikari, Abhijeet; Plested, Joyce S; Cloney-Clarke, Shane; Zhu, Mingzhu; Pryor, Melinda; Hamilton, Stephanie; Thakar, Madhuri; Shete, Ashwini; Gautam, Manish; Gupta, Nivedita; Panda, Samiran; Shaligram, Umesh; Poonawalla, Cyrus S; Bhargava, Balram; Gunale, Bhagwat; Kapse, Dhananjay
